Dianthus Therapeutics (DNTH) Ownership - Who Owns Dianthus Therapeutics?

437 Followers

Dianthus Therapeutics (DNTH) Ownership Overview

0.12% Insiders

19.77% Mutual Funds

1.86% Other Institutional Investors

9.56% ETFs

68.70% Public Companies and

Individual Investors

The ownership structure of Dianthus Therapeutics (DNTH) stock is a mix of institutional, retail, and individual investors. Approximately 31.18% of the company’s stock is owned by Institutional Investors, 0.12% is owned by Insiders, and 68.70% is owned by Public Companies and Individual Investors.

The ownership structure of Dianthus Therapeutics (DNTH) stock is a mix of institutional, retail, and individual investors. Approximately 21.62% of the company’s stock is owned by Institutional Investors, 0.12% is owned by Insiders, and 9.56% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Fairmount Funds Management Llc	xxxxxxxxxxxxx	$88073641
Dec 31, 2023	Ra Capital Management	xxxxxxxxxxxxx	$66419517
Dec 31, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$8781315
Dec 31, 2023	Antipodes Partners Ltd	xxxxxxxxxxxxx	$18915

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	2,319,684	Institution	4.24%	202,090,870
Peter Harwin	2,137,191	Institution	3.91%	186,192,080
	1,841,581	Institution	3.37%	160,438,537
Peter Kolchinsky	1,611,733	Institution	2.95%	140,414,179
	1,574,735	Institution	2.88%	137,190,913
	1,568,877	Institution	2.87%	136,680,564
	1,339,984	Institution	2.45%	116,739,406
	1,168,805	Institution	2.14%	101,826,292
Felix Baker	789,759	Institution	1.44%	68,803,804
	730,062	Institution	1.34%	63,603,001

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,841,581	Institution	3.37%	160,438,537
1,574,735	Institution	2.88%	137,190,913
1,568,877	Institution	2.87%	136,680,564
1,168,805	Institution	2.14%	101,826,292
730,062	Institution	1.34%	63,603,001
454,318	Institution	0.83%	39,580,184
432,218	Institution	0.79%	37,654,832
367,062	Institution	0.67%	31,978,441
366,946	Institution	0.67%	31,968,336
346,701	Institution	0.63%	30,204,591

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	1,566,017	Institution	2.86%	131,420,147
iShares Russell 2000 ETF	844,364	Institution	1.54%	73,560,992
SPDR S&P BIOTECH ETF	638,146	Institution	1.17%	55,333,640
Vanguard Extended Market ETF	412,546	Institution	0.75%	34,620,860
iShares Russell 2000 Value ETF	280,175	Institution	0.51%	24,408,846
Schwab U.S. Small-Cap ETF	179,509	Institution	0.33%	15,565,225
Vanguard Russell 2000 ETF	176,511	Institution	0.32%	14,812,803
Vanguard Health Care ETF	104,889	Institution	0.19%	8,802,285
iShares Micro-Cap ETF	92,161	Institution	0.17%	8,029,066
Dimensional U.S. Small Cap ETF	71,218	Institution	0.13%	6,175,313

FAQ

Who Owns Dianthus Therapeutics (DNTH)?

According to the latest TipRanks data, approximately 1.86% of the company's stock is held by institutional investors, 0.12% is held by insiders, and 68.70% is held by retail investors.

What percentage of Dianthus Therapeutics (DNTH) stock is held by institutional investors?

According to the latest TipRanks data, approximately 1.86% of Dianthus Therapeutics (DNTH) stock is held by institutional investors.

What percentage of Dianthus Therapeutics (DNTH) stock is held by retail investors?

According to the latest TipRanks data, approximately 68.70% of Dianthus Therapeutics (DNTH) stock is held by retail investors.

Who owns the most shares of Dianthus Therapeutics (DNTH)?

Vanguard owns the most shares of Dianthus Therapeutics (DNTH).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.